Lenalidomid verstärkt die MOR202-abhängigen Makrophagen-vermittelten Effektorfunktionen über den Vitamin D Signalweg

Autor: Busch, Leonhard

Macrophages are key mediators of the therapeutic effects exerted by monoclonal antibodies, such as the anti-CD38 antibody MOR202, currently introduced in multiple myeloma (MM) therapy. Therefore, it is important to understand how antibody-mediated ef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2091::659bcb20dd02ef1babda6105cfd1c789
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/21183

Vitamin D Blocks CLL Cell-Mediated MDSC Induction

Autor: Mougiakakos, Dimitrios ^*, Bruns, Heiko ^*, Böttcher, Martin ^*, Qorraj, Mirjeta ^*, Fabri, Mario ^*, Dindorf, Jochen ^*, Busch, Leonhard ^*, Jitschin, Regina ^*, Mackensen, Andreas

Publikováno v: In Blood 2 December 2016 128(22):4355-4355

Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tango.

Autor: Flamann C; Heiko Bruns: Department of Internal Medicine 5-Hematology/Oncology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Busch L; Heiko Bruns: Department of Internal Medicine 5-Hematology/Oncology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Mackensen A; Heiko Bruns: Department of Internal Medicine 5-Hematology/Oncology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Bruns H; Heiko Bruns: Department of Internal Medicine 5-Hematology/Oncology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.

Publikováno v: Oncotarget [Oncotarget] 2019 Jan 01; Vol. 10 (1), pp. 10-12. Date of Electronic Publication: 2019 Jan 01 (Print Publication: 2019).